Introduction Drug discovery is a long, costly, and high-risk process. Developing an innovative drug, from initial research to market launch, typically spans 10 to 15 years, with an average cost of $1Read More…
Introduction The pharmaceutical industry is facing an unprecedented challenge in drug discovery, with the cost of developing new drugs soaring to an estimated $6.16 billion in 2023—more than double the adjusted costRead More…
Introduction The rapid evolution of artificial intelligence (AI) has revolutionized multiple sectors, including the pharmaceutical industry. A review article titled “The Applications and Advances of Artificial Intelligence in Drug Regulation: A GlobalRead More…
The 2024 Nobel Prizes brought artificial intelligence (AI) to the forefront, with groundbreaking work recognized in physics and chemistry. On October 8, the Nobel Prize in Physics was awarded to two pioneersRead More…
Introduction to AI and ML in Rare Disease Research Artificial intelligence (AI) and machine learning (ML) tools, once used primarily for developing structured datasets, have now successfully ventured into the realm ofRead More…
The Game-Changing Role of AI in Small Molecule Design for Drug Development Artificial intelligence (AI) is reshaping the landscape of drug discovery and development, especially in the field of small-molecule design. ThisRead More…
Artificial intelligence (AI) is significantly transforming antibody engineering, leading to faster, more efficient, and highly innovative drug discovery processes. Recent advancements in AI technology have shown remarkable progress in designing, optimizing, andRead More…
In the fast-paced realm of antibody discovery, artificial intelligence (AI) has emerged as a game-changer, vastly speeding up research and development. The past few months have seen remarkable studies and innovations, underscoringRead More…
In the era following the advancement of drug research, artificial intelligence (AI) has emerged as a leading force in pharmaceutical development. In recent years, the pharmaceutical industry has witnessed a significant shiftRead More…
The rise of small molecule drugs discovered through artificial intelligence is a notable trend where computer science and life science converge. Fragment-based drug discovery (FBDD) has emerged as a new approach inRead More…